4.5 Article

Delineating differential regulatory signatures of the human transcriptome in the choriodecidua and myometrium at term labor

Journal

BIOLOGY OF REPRODUCTION
Volume 98, Issue 3, Pages 422-436

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/biolre/iox186

Keywords

decidua; endometrium; gene expression; immunology; molecular biology; myometrium; parturition; pregnancy; labor

Funding

  1. James Tudor Foundation
  2. Tommy's the Baby Charity
  3. Manchester BRC
  4. Greater Manchester CLRN
  5. BBSRC David Phillips Research Fellowship
  6. SickKids Foundation
  7. Canadian Institutes of Health Research Institute of Human Development, Child and Youth Health
  8. Tommy's the Baby Charity, an Action Research Endowment Fund
  9. Medical Research Council [MR/N010892/1] Funding Source: researchfish
  10. MRC [MR/N010892/1] Funding Source: UKRI

Ask authors/readers for more resources

Preterm deliveries remain the leading cause of neonatal morbidity and mortality. Current therapies target only myometrial contractions and are largely ineffective. As labor involves multiple coordinated events across maternal and fetal tissues, identifying fundamental regulatory pathways of normal term labor is vital to understanding successful parturition and consequently labor pathologies. We aimed to identify transcriptomic signatures of human normal term labor of two tissues: in the fetal-facing choriodecidua and the maternalmyometrium. Microarray transcriptomic data from choriodecidua and myometrium following term labor were analyzed for functional hierarchical networks, using Cytoscape 2.8.3. Hierarchically high candidates were analyzed for their regulatory casual relationships using Ingenuity Pathway Analysis. Selectedmaster regulators were then chemically inhibited and effects on downstream targets were assessed using real-time quantitative PCR (RT-qPCR). Unbiased network analysis identified upstream molecular components in choriodecidua including vimentin, TLR4, and TNFSF13B. In the myometrium, candidates included metallothionein 2 (MT2A), TLR2, and RELB. These master regulators had significant differential gene expression during labor, hierarchically high centrality in community cluster networks, interactions amongst the labor gene set, and strong causal relationships with multiple downstream effects. In vitro experiments highlighted MT2A as an effective regulator of labor-associated genes. We have identified unique potential regulators of the term labor transcriptome in uterine tissues using a robust sequence of unbiased mathematical and literature-based in silico analyses. These findings encourage further investigation into the efficacy of predicted master regulators in blocking multiple pathways of labor processes across maternal and fetal tissues, and their potential as therapeutic approaches. Summary Sentence Combined in silico and in vitro analyses have identified novel transcriptomic regulators of term labor in human choriodecidua and myometrium with further therapeutic potential.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biology

The lexicon of antimicrobial peptides: a complete set of arginine and tryptophan sequences

Sam Clark, Thomas A. Jowitt, Lynda K. Harris, Christopher G. Knight, Curtis B. Dobson

Summary: Clark et al. comprehensively explore the primary structural features underlying the activity of a complete set of antimicrobial peptides (AMPs). They find that the shortest active peptides were 4 or 5 residues in length, with activity being associated with 40% arginine, and multiple adjacent tryptophan residues. This study provides insights into the design of effective AMPs.

COMMUNICATIONS BIOLOGY (2021)

Article Medicine, General & Internal

Multidisciplinary management of pregnancy and labour in a patient with glycogen storage disease type 1a

Alice May Jones, Clare Tower, Diane Green, Karolina M. Stepien

Summary: Glycogen storage disease type 1a in pregnancy requires multidisciplinary team management, with continuous monitoring of metabolic parameters, regular growth scans, and various methods to control the risks of hypoglycemia and lactic acidosis. Through comprehensive management, maternal and fetal care can be optimized, ensuring successful vaginal delivery.

BMJ CASE REPORTS (2021)

Article Endocrinology & Metabolism

miR-514a-3p: a novel SHP-2 regulatory miRNA that modulates human cytotrophoblast proliferation

Rachel C. Quilang, Sylvia Lui, Karen Forbes

Summary: The study reveals that miR-514a-3p regulates the expression of SHP-2 and affects IGF signaling and trophoblast proliferation in the human placenta, suggesting its therapeutic potential in pregnancy complications associated with altered placental growth.

JOURNAL OF MOLECULAR ENDOCRINOLOGY (2022)

Article Medicine, Research & Experimental

Conjugation to PEG as a Strategy to Limit the Uptake of Drugs by the Placenta: Potential Applications for Drug Administration in Pregnancy

Abbie Dodd, Az Alddien Natfji, Angelos Evangelinos, Antonella Grigoletto, Gianfranco Pasut, Frances Beards, Lewis Renshall, Helen M. Osborn, Francesca Greco, Lynda K. Harris

Summary: This study evaluated the feasibility of non-prodrug PEG-drug conjugates in reducing drug accumulation in placental tissues. Results showed that PEG was biocompatible with human placenta, with no impact on cell proliferation or apoptosis rates. Treatment with PEG did not cause significant changes in lactate dehydrogenase levels or human chorionic gonadotropin release. Cellular uptake studies demonstrated that conjugating Cy5.5 and haloperidol to PEG resulted in a significant reduction (up to approximately 40-fold) in their uptake by the placenta.

MOLECULAR PHARMACEUTICS (2022)

Article Endocrinology & Metabolism

Sexually dimorphic patterns in maternal circulating microRNAs in pregnancies complicated by fetal growth restriction

Bernadette C. Baker, Sylvia Lui, Isabel Lorne, Alexander E. P. Heazell, Karen Forbes, Rebecca L. Jones

Summary: The study identified sexually dimorphic patterns for miRNAs in maternal serum in FGR, suggesting their potential as non-invasive biomarkers for FGR and associated placental dysfunction. The miRNAs showed correlations with potential functions in placental dysfunction, offering insights into the pathogenesis of placental dysfunction and the differing susceptibility of male and female fetuses to adverse in utero conditions.

BIOLOGY OF SEX DIFFERENCES (2021)

Article Pharmacology & Pharmacy

Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction

Lewis J. Renshall, Frances Beards, Angelos Evangelinos, Susan L. Greenwood, Paul Brownbill, Adam Stevens, Colin P. Sibley, John D. Aplin, Edward D. Johnstone, Tambet Teesalu, Lynda K. Harris

Summary: This study demonstrates the potential of using EGF-loaded, peptide-decorated liposomes to improve placental function. GPS-decorated liposomes containing EGF significantly increased amino acid transporter activity in healthy placental tissues, but were ineffective in those from pregnancies with FGR. Targeted liposomes represent a safe and useful tool for developing new therapies for placental dysfunction.

PHARMACEUTICS (2021)

Article Medicine, General & Internal

Immunomodulatory Therapy Reduces the Severity of Placental Lesions in Chronic Histiocytic Intervillositis

Chloe A. Brady, Charlotte Williams, Gauri Batra, Elaine Church, Clare L. Tower, Ian P. Crocker, Alexander E. P. Heazell

Summary: CHI is a rare placental lesion characterized by maternal macrophages infiltration, posing risks of fetal growth restriction, miscarriage, or stillbirth. Immunomodulatory medications, such as prednisolone and hydroxychloroquine, have shown promising results in reducing lesion severity and improving livebirth rates in subsequent pregnancies for women with a history of CHI.

FRONTIERS IN MEDICINE (2021)

Article Reproductive Biology

Placental expression of estrogen-related receptor gamma is reduced in fetal growth restriction pregnancies and is mediated by hypoxia†

Zhiyong Zou, Lynda K. Harris, Karen Forbes, Alexander E. P. Heazell

Summary: Fetal growth restriction (FGR) is closely related to placental dysfunction and hypoxia. The decreased signaling of estrogen-related receptor gamma (ESRRG) in hypoxic conditions may contribute to hypoxia-induced placental dysfunction in FGR. The ESRRG agonist DY131 has the potential to restore hypoxic damages and could be used as a therapeutic approach for the treatment of placental dysfunction.

BIOLOGY OF REPRODUCTION (2022)

Article Reproductive Biology

Sex-specific effects of bisphenol A on the signaling pathway of ESRRG in the human placenta†

Zhiyong Zou, Lynda K. Harris, Karen Forbes, Alexander E. P. Heazell

Summary: This study demonstrates that BPA affects the ESRRG signaling pathway in a sex-specific manner in human placentas, providing a possible biological mechanism to explain the differential effects of BPA exposure on male and female fetuses observed in epidemiological studies.

BIOLOGY OF REPRODUCTION (2022)

Article Obstetrics & Gynecology

Digital screening for postnatal depression: mixed methods proof-of-concept study

Emily Eisner, Shon Lewis, Charlotte Stockton-Powdrell, Ria Agass, Pauline Whelan, Clare Tower

Summary: This study developed a smartphone app to improve access to postnatal depression (PND) treatment. The app was found to be feasible, acceptable, valid, and safe, and it also overcomes some of the limitations of conventional health visitor-delivered screening.

BMC PREGNANCY AND CHILDBIRTH (2022)

Article Pharmacology & Pharmacy

Internal Mammary Arteries as a Model to Demonstrate Restoration of the Impaired Vasodilation in Hypertension, Using Liposomal Delivery of the CYP1B1 Inhibitor, 2,3′,4,5′-Tetramethoxystilbene

Azziza Zaabalawi, Lewis Renshall, Frances Beards, Adam P. Lightfoot, Hans Degens, Yvonne Alexander, Ragheb Hasan, Haris Bilal, Brigitte A. Graf, Lynda K. Harris, May Azzawi

Summary: This study investigates the use of liposome-encapsulated TMS to improve vasodilator function in patients undergoing CABG. The results demonstrate that TMS-loaded liposomes can enhance vasodilation by inhibiting CYP1B1 and reducing reactive oxygen species, and suggest the potential of TMS-loaded liposomes as a therapeutic strategy for the treatment of hypertension in CABG patients.

PHARMACEUTICS (2022)

Review Respiratory System

Acute respiratory distress syndrome: potential of therapeutic interventions effective in treating progression from COVID-19 to treat progression from other illnesses-a systematic review

Emma J. Ragel, Lynda K. Harris, Richard A. Campbell

Summary: ARDS is a severe form of lung injury leading to respiratory failure, with no robust pharmacological treatments available. The optimal treatment for COVID-19 ARDS may differ from ARDS developed from other illnesses due to differences in pathology. New therapeutic interventions developed for CARDS may hold strong potential in treating ARDS developed from other illnesses.

BMJ OPEN RESPIRATORY RESEARCH (2023)

Meeting Abstract Developmental Biology

DY131 RESCUES ABNORMAL TROPHOBLAST TURNOVER AND IMPAIRED OESTROGEN RELATED RECEPTOR GAMMA SIGNALLING INDUCED BY HYPOXIA

Zhiyong Zou, Lynda K. Harris, Karen Forbes, Alexander E. P. Heazell

PLACENTA (2022)

Article Rheumatology

Pregnancy outcomes of a joint obstetric and rheumatology clinic in a tertiary centre: a 2-year retrospective study of 98 pregnancies

Ryan Malcolm Hum, Trixy David, Yen June Lau, Hajira Iftikhar, Sue Thornber, Louise Simcox, Ian Bruce, Clare Tower, Pauline Ho

Summary: This study aimed to describe maternal and fetal outcomes in patients with inflammatory rheumatic diseases attending a joint rheumatology and obstetric clinic in the UK. Electronic records of 98 patients were analyzed, revealing favorable outcomes such as a high live birth rate, low miscarriage rate, and high median birth weight. Such joint obstetric/rheumatology clinics may be beneficial in other centers given the limited reported data on pregnancy outcomes.

RHEUMATOLOGY ADVANCES IN PRACTICE (2022)

Meeting Abstract Obstetrics & Gynecology

miR-377 Downregulates Placental ESRRG Expression Which is Related toAbnormal Cell Turnover.

Zhiyong Zou, Lynda K. Harris, Karen Forbes, Alexander E. P. Heazell

REPRODUCTIVE SCIENCES (2022)

No Data Available